Why the study?
Are serum lipocalin-2 and visfatin levels associated with coronary heart disease and cardiovascular risk factors?
Are serum lipocalin-2 and visfatin levels associated with coronary heart disease and cardiovascular risk factors?
Serum lipocalin-2 levels are significantly elevated in patients with coronary heart disease and independently associated with cardiovascular risk factors like insulin resistance, suggesting potential utility as a biomarker for CHD risk.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for lipocalin-2 as CHD biomarker; should not change practice pending prospective validation.
Choi et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: